EU officials to review Sanofi's quadrivalent flu vaccine

04/11/2013 | Reuters

Sanofi said European regulators have accepted its marketing application for a quadrivalent version of its Vaxigrip flu vaccine. The new vaccine is designed to fight the four strains of flu virus anticipated in the coming season. Sanofi plans to apply for marketing approval in all countries where the three-strain Vaxigrip is currently marketed.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY